Recursion Receives ISS ESG Prime Rating and Plans to Participate in the Goldman Sachs Global Sustainability Forum

(marketscreener.com) SALT LAKE CITY, Aug. 18, 2022 /PRNewswire/ -- Recursion , the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced that it recently received a Prime Rating for ESG performance from the industry-renowned Institutional Shareholder Services , which is the first time Recursion has been ranked by...https://www.marketscreener.com/quote/stock/RECURSION-PHARMACEUTICALS-121456074/news/Recursion-Receives-ISS-ESG-Prime-Rating-and-Plans-to-Participate-in-the-Goldman-Sachs-Global-Sustain-41352908/?utm_medium=RSS&utm_content=20220818